Market capitalization | €25.91b |
Enterprise Value | €29.57b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 33.84 |
EV/Sales (TTM) EV/Sales | 2.37 |
P/S ratio (TTM) P/S ratio | 2.08 |
P/B ratio (TTM) P/B ratio | 1.17 |
Dividend yield | 2.56% |
Last dividend (FY24) | €2.50 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
22 Analysts have issued a DSM-Firmenich forecast:
22 Analysts have issued a DSM-Firmenich forecast:
Jun '24 |
+/-
%
|
||
Revenue | 12,455 12,455 |
96%
96%
|
|
Gross Profit | 3,844 3,844 |
89%
89%
|
|
EBITDA | 1,796 1,796 |
18%
18%
|
EBIT (Operating Income) EBIT | 488 488 |
174%
174%
|
Net Profit | -190 -190 |
14%
14%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. The firm offers a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet. The company was founded on May 16, 2022 and is headquartered in Kaiseraugst, Switzerland.
Head office | Switzerland |
CEO | Dimitri Vreeze |
Employees | 29,301 |
Founded | 1902 |
Website | www.dsm-firmenich.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.